Directori de persones
Nuria Eritja Sanchez

Nuria Eritja Sanchez

Grau: Doctor/a

973 70 29 37
neritja(ELIMINAR)@irblleida.cat

ResearcherID: http://www.researcherid.com/rid/M-1347-2015

Grups

Publicacions

  • Mirantes, C; Dosil, MA; Eritja, N; Felip, I; Gatius, S; Santacana, M; Matias-Guiu, X; Dolcet, X

    Effects of the multikinase inhibitors Sorafenib and Regorafenib in PTEN deficient neoplasias

    EUROPEAN JOURNAL OF CANCER 63 74-87. .

    [doi:10.1016/j.ejca.2016.04.019]

  • Mirantes, C; Dosil, MA; Hills, D; Yang, J; Eritja, N; Santacana, M; Gatius, S; Vilardell, F; Medvinsky, A; Matias-Guiu, X; Dolcet, X

    Deletion of Pten in CD45-expressing cells leads to development of T-cell lymphoblastic lymphoma but not myeloid malignancies

    Blood 127 1907-1911. .

    [doi:10.1182/blood-2015-09-669036]

  • Eritja, N; Arjo, G; Santacana, M; Gatius, S; Ramirez-Nunez, O; Arcal, L; Serrano, JCE; Pamplona, R; Dolcet, X; Pinol, C; Christou, P; Matias-Guiu, X; Portero-Otin, M

    Oral intake of genetically engineered high-carotenoid corn ameliorates hepatomegaly and hepatic steatosis in PTEN haploinsufficient mice

    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE 1862 526-535. .

    [doi:10.1016/j.bbadis.2016.01.018]

  • Eritja N; Santacana M; Maiques O; Gonzalez-Tallada X; Dolcet X; Matias-Guiu X

    Modeling glands with PTEN deficient cells and microscopic methods for assessing PTEN loss: Endometrial cancer as a model

    Methods 77-78 31-40. .

    [doi:10.1016/j.ymeth.2014.11.001]

  • Alonso-Alconada L; Eritja N; Muinelo-Romay L; Barbazan J; Lopez-Lopez R; Matias-Guiu X; Gil-Moreno A; Dolcet X; Abal M

    ETV5 transcription program links BDNF and promotion of EMT at invasive front of endometrial carcinomas

    CARCINOGENESIS 35 2679-2686. .

    [doi:10.1093/carcin/bgu198]

  • Eritja N; Domingo M; Dosil MA; Mirantes C; Santacana M; Valls J; Llombart-Cussac A; Matias-Guiu X; Dolcet X

    Combinatorial Therapy Using Dovitinib and ICI182.780 (Fulvestrant) Blocks Tumoral Activity of Endometrial Cancer Cells

    MOLECULAR CANCER THERAPEUTICS 13 776-787. .

    [doi:10.1158/1535-7163.MCT-13-0794]

  • Eritja, Nuria; Dolcet, Xavier; Matias-Guiu, Xavier

    Three-dimensional epithelial cultures: a tool to model cancer development and progression

    HISTOLOGY AND HISTOPATHOLOGY 28 1245-1256. .

    [doi:10.14670/HH-28.1245]

  • Bergadà L; Sorolla A; Yeramian A; Eritja N; Mirantes C; Matias-Guiu X; Dolcet X

    Combination of Vorinostat and caspase-8 inhibition exhibits high anti-tumoral activity on endometrial cancer cells

    MOLECULAR ONCOLOGY 7 763-775. .

    [doi:10.1016/j.molonc.2013.03.003]

  • Eritja N; Mirantes C; Llobet D; Yeramian A; Bergadà L; Dosil MA; Domingo M; Matias-Guiu X; Dolcet X

    Long-Term Estradiot Exposure Is a Direct Mitogen for Insulin/EGF-Primed Endometriat Cells and Drives PTEN Loss-Induced Hyperplasic Growth

    AMERICAN JOURNAL OF PATHOLOGY 183 277-287. .

    [doi:10.1016/j.ajpath.2013.03.008]

  • Chen, N.; Eritja, N.; Lock, R.; Debnath, J.

    Autophagy restricts proliferation driven by oncogenic phosphatidylinositol 3-kinase in three-dimensional culture

    ONCOGENE 32 2543-2554. .

    [doi:10.1038/onc.2012.277]

  • Mirantes C; Eritja N; Dosil MA; Santacana M; Pallares J; Gatius S; Bergadà L; Maiques O; Matias-Guiu X; Dolcet X

    An inducible knockout mouse to model the cell-autonomous role of PTEN in initiating endometrial, prostate and thyroid neoplasias

    DISEASE MODELS & MECHANISMS 6 710-720. .

    [doi:10.1242/dmm.011445]

  • Eritja, Nuria; Mirantes, Cristina; Llobet, David; Masip, Gemma; Matias-Guiu, Xavier; Dolcet, Xavi

    ER alpha-mediated repression of pro-inflammatory cytokine expression by glucocorticoids reveals a crucial role for TNF alpha and IL1 alpha in lumen formation and maintenance

    JOURNAL OF CELL SCIENCE 125 1929-1944. .

    [doi:10.1242/jcs.095067]

Projectes

  • Implicación de ARID1A en la remodelación del microambiente tumoral y la reprogramación metabólica en el cáncer endometrial
  • Papel de ARID1A en la carcinogénesis endometrial dependiente de contexto. Análisis de los mecanismos moleculares y posibles implicaciones terapéuticas
  • Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
  • Contrato Miguel Servet - RRHH
  • Contrato Miguel Servet - Proyecto
  • LYOTEK
  • "Determinación del perfil metabólico del carcinoma endometrioide de endometrio grado 3 para discriminar los subtipos tumorales establecidos por clasificación del TCGA (The Cancer Genome Atlas Research Network)"
  • EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
  • Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
  • CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
  • DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
  • Genomic approach for individualizing endometrial cancer diagnosis, prognosis and treatment